openPR Logo
Press release

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of "FOCUSfactor Registered " Energy Drink - More Stocks Moving Inside

06-10-2025 10:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate

Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company's FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.

This pivotal hire signals Synergy's bold intentions to aggressively scale its presence in the surging $100B+ functional beverage sector. With over two decades of leadership in sales, revenue growth, and digital innovation, Marano is expected to play a central role in expanding FOCUSfactor Energy Drink's reach across North America and key global territories.

Marano's deep knowledge of Coca-Cola's global sales infrastructure-and his relationships across its vast distribution ecosystem-could offer Synergy a rare pathway to accelerate the international rollout of its FOCUSfactor Energy Drink line. His past success building the Marley wellness portfolio into a global brand distributed in over 25,000 stores across 40 countries provides a strong precedent. Roth Capital Update June 10, 2025 [https://thestreetreports.com/wp-content/uploads/2025/06/SNYR-Roth-updated-report.pdf]

In addition to Synergy CHC Corp. (NASDAQ: SNYR), news keep an eye on other stocks making news: Klotho Neurosciences, Inc . (NASDAQ: KLTO), Evogene Ltd. (NASDAQ: EVGN), Plug Power Inc. (NASDAQ: PLUG), MacroGenics, Inc. (Nasdaq: MGNX), Power Metallic Mines Inc. (TSXV: PNPN) (OTCQB: PNPNF) and Windtree Therapeutics, Inc. (Nasdaq: WINT), as they are moving aggressively in early trading today.

"Damian's appointment brings unmatched beverage industry leadership to our team," said Jack Ross, CEO of Synergy CHC. "His proven success scaling consumer brands and deploying tech-driven sales strategies is a game-changer as we position FOCUSfactor Energy to become a category leader."

The energy drink, launched as a clean-label, nootropic-infused extension of Synergy's flagship FOCUSfactor brain health supplement, is already gaining traction in major retail chains including Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS), and Walgreens (NASDAQ: WBA). With Marano now at the helm of beverage strategy, Synergy is poised to capture new market share in both domestic and international better-for-you drink segments.

As Synergy leverages its legacy in cognitive health and a growing distribution footprint, the addition of a Coca-Cola veteran could be the catalyst that propels FOCUSfactor Energy Drink into a globally recognized brand.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=synergy-chc-nasdaq-snyr-taps-cocacola-exec-to-accelerate-global-expansion-of-focusfactor-energy-drink-more-stocks-moving-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of "FOCUSfactor Registered " Energy Drink - More Stocks Moving Inside here

News-ID: 4060389 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases


More Releases for Synergy

The Synergy Between Regulatory Intelligence and Pharmacovigilance
In the ever-evolving landscape of life sciences and healthcare, regulatory intelligence (RI) and pharmacovigilance (PV) play critical roles. Companies face multifaceted challenges that span across regulatory compliance, safety monitoring, and strategic decision-making. This is where experts like Celegence and Soterius come into play to bridge the gap between RI and PV. Celegence offers a team of regulatory experts (https://www.celegence.com/services/regulatory-intelligence-solutions/) who understand the nuances of global regulations. They provide real-time
SAP Integration Unveils Seamless Supply Chain Synergy
Integrating SAP S/4HANA with SAP Business Network for Logistics offers a multitude of strategic advantages, revolutionizing supply chain operations. The marriage of these two platforms aligns with the contemporary imperative of streamlined, agile, and data-driven logistics. SAP S/4HANA ( https://businessprocessxperts.com/sap-s-4hana-transformations-with-sap-signavio/ ), renowned for its real-time analytics and centralized data management, serves as the cornerstone of digital transformation in enterprises. Its integration with the SAP Business Network amplifies these capabilities specifically within
Professional Cosmetic Synergy Gel | Weero
WEERO has been a global manufacturer providing first-class aesthetic devices to the world since its establishment in 2015. Weero manufactures, distributes and exports aesthetic medical devices, aesthetic S/W program, and professional cosmetic solutions to customers of the aesthetic industry who have been looking for high-quality and trendy items. Weero Synergy Gel  Weero Synergy gel is a professional conductive gel that contains peptides and HA complex to maximize the skin improvement result of an
SYNERGY – Harmonious mixture of materials
The new SYNERGY range of enclosures combines the advantages of the attractive material combination of aluminium and plastic with an extremely elegant look. The purist enclosure design uses the basic geometrical shapes of square, rectangular, circular and oval. The combination of three sizes for each basic shape, each in three different heights, means 36 enclosures which offer optimum protection as well as the sophisticated presentation of the electronics. The potential
SYNERGY HomeCare Earns Home Care Pulse Certification
SYNERGY HomeCare today announced the completion of a comprehensive national client satisfaction benchmarking research project with Home Care Pulse. SYNERGY HomeCare is now officially a Home Care Pulse certified quality home care provider. “Home Care Pulse certification reinforces SYNERGY HomeCare’s commitment to provide the highest level of quality care”, says Dallas Bennewitz, Vice President of Marketing for SYNERGY HomeCare. “Our clients now have additional proof of our dedication to provide compassionate
SYNERGY HomeCare Opens New Office in Beaverton
Beaverton, OR (Grassroots Newswire) 3-6-2012 -- SYNERGY HomeCare, one of the nation’s leading home care providers, today announced the opening of its new location at 6700 SW 105th Ave. Suite 303 Beaverton, OR 97008. The new SYNERGY HomeCare office is situated on the intersection of Denney and Highway 217. The Beaverton office is open from 8 am to 5 pm Monday through Friday providing care services 24 hours a